These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21740850)

  • 21. Generation of human-induced pluripotent stem cells.
    Park IH; Lerou PH; Zhao R; Huo H; Daley GQ
    Nat Protoc; 2008; 3(7):1180-6. PubMed ID: 18600223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induced pluripotent stem (iPS) cell research overview.
    Liu SP; Fu RH; Huang YC; Chen SY; Chien YJ; Hsu CY; Tsai CH; Shyu WC; Lin SZ
    Cell Transplant; 2011; 20(1):15-9. PubMed ID: 20887681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatic cell nuclear transfer: pros and cons.
    Sumer H; Liu J; Tat P; Heffernan C; Jones KL; Verma PJ
    J Stem Cells; 2009; 4(2):85-93. PubMed ID: 20232594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances and applications of induced pluripotent stem cells.
    Pietronave S; Prat M
    Can J Physiol Pharmacol; 2012 Mar; 90(3):317-25. PubMed ID: 22364544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells.
    Pick M; Stelzer Y; Bar-Nur O; Mayshar Y; Eden A; Benvenisty N
    Stem Cells; 2009 Nov; 27(11):2686-90. PubMed ID: 19711451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induced pluripotent stem cells' self-renewal and pluripotency is maintained by a bovine granulosa cell line-conditioned medium.
    Solari C; Losino N; Luzzani C; Waisman A; Bluguermann C; Questa M; Sevlever G; Miriuka S; Barañao L; Guberman A
    Biochem Biophys Res Commun; 2011 Jul; 410(2):252-7. PubMed ID: 21651896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The generation of iPS cells using non-viral magnetic nanoparticle based transfection.
    Lee CH; Kim JH; Lee HJ; Jeon K; Lim H; Choi Hy; Lee ER; Park SH; Park JY; Hong S; Kim S; Cho SG
    Biomaterials; 2011 Oct; 32(28):6683-91. PubMed ID: 21683440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
    Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
    Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Present status on studies of differentiation into retinal neurons and pigmented cell from induced pluripotent stem cells].
    Meng FX; Guo WY
    Zhonghua Yan Ke Za Zhi; 2010 Dec; 46(12):1139-42. PubMed ID: 21211229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accelerating progress in induced pluripotent stem cell research for neurological diseases.
    Ito D; Okano H; Suzuki N
    Ann Neurol; 2012 Aug; 72(2):167-74. PubMed ID: 22926850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural and artificial routes to pluripotency.
    Krueger WH; Swanson LC; Tanasijevic B; Rasmussen TP
    Int J Dev Biol; 2010; 54(11-12):1545-64. PubMed ID: 21404178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From skin to the treatment of diseases--the possibilities of iPS cell research in dermatology.
    Galach M; Utikal J
    Exp Dermatol; 2011 Jun; 20(6):523-8. PubMed ID: 21585557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of MEF feeder cells in direct reprogramming of mousetail-tip fibroblasts.
    Chen M; Sun X; Jiang R; Shen W; Zhong X; Liu B; Qi Y; Huang B; Xiang AP; Ge J
    Cell Biol Int; 2009 Dec; 33(12):1268-73. PubMed ID: 19524692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single transcription factor reprogramming of hair follicle dermal papilla cells to induced pluripotent stem cells.
    Tsai SY; Bouwman BA; Ang YS; Kim SJ; Lee DF; Lemischka IR; Rendl M
    Stem Cells; 2011 Jun; 29(6):964-71. PubMed ID: 21563278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telomere rejuvenation during nuclear reprogramming.
    Marión RM; Blasco MA
    Curr Opin Genet Dev; 2010 Apr; 20(2):190-6. PubMed ID: 20176474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospects for pluripotent stem cell therapies: into the clinic and back to the bench.
    Grabel L
    J Cell Biochem; 2012 Feb; 113(2):381-7. PubMed ID: 21928325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [An overview of pluripotent stem cell lines].
    Kieffer E; Kuntz S; Viville S
    Med Sci (Paris); 2010 Oct; 26(10):848-54. PubMed ID: 20929676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel strategy to derive iPS cells from porcine fibroblasts.
    Ruan W; Han J; Li P; Cao S; An Y; Lim B; Li N
    Sci China Life Sci; 2011 Jun; 54(6):553-9. PubMed ID: 21706416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent progressions in stem cell research: breakthroughs achieved and challenges faced.
    Tani J; Umbas R
    Acta Med Indones; 2009 Jan; 41(1):30-5. PubMed ID: 19258678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A commentary on iPS cells: potential applications in autologous transplantation, study of illnesses and drug screening.
    Romano G; Morales F; Marino IR; Giordano A
    J Cell Physiol; 2014 Feb; 229(2):148-52. PubMed ID: 23881704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.